Meeder Asset Management’s Tectonic Therapeutic TECX Stock Holding History
Bought
Maintained
Sold
Other funds holding TECX
EAM
CCM
SHI
FCM
ACM
Meeder Asset Management's TECX Position: Q3 2020 in Review
Meeder Asset Management sold out of Tectonic Therapeutic (TECX) in Q3 2020, closing a stake of 251 shares — an estimated $53K sold.
Meeder Asset Management first reported a position in TECX in Q2 2019 and held it in 5 quarters. The position peaked at $53K in Q2 2020. 101 funds tracked by Wall St. Rank hold TECX as of Q3 2020.
- Meeder Asset Management reported no remaining Tectonic Therapeutic position as of Q3 2020 after selling out during the quarter.
- Meeder Asset Management sold 251 Tectonic Therapeutic shares in Q3 2020, an estimated $53K.
- Meeder Asset Management first reported a position in Tectonic Therapeutic in Q2 2019 and held it in 5 quarters.
- Meeder Asset Management's Tectonic Therapeutic position peaked at $53K in Q2 2020.
- 101 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2020.
Based on Meeder Asset Management's 13F filing for Q3 2020, filed 2 Nov 2020.